Apollo Hospitals Enterprise Ltd’s fundamental analysis highlights key financial metrics including market capitalization of ₹94,723 crore, PE ratio of 106, debt-to-equity ratio of 0.77, and return on equity of 13.7%. These figures reflect the company’s financial health and current market valuation.
Content:
- Apollo Hospitals Enterprise Ltd Overview
- Apollo Hospitals Enterprise Financial Results
- Apollo Hospitals Enterprise Financial Analysis
- Apollo Hospitals Enterprise Company Metrics
- Apollo Hospitals Enterprise Stock Performance
- Apollo Hospitals Enterprise Peer Comparison
- Apollo Hospitals Enterprise Shareholding Pattern
- Apollo Hospitals Enterprise History
- How To Invest In Apollo Hospitals Enterprise Ltd Share?
- Apollo Hospitals Enterprise Limited Fundamental Analysis – FAQs
Apollo Hospitals Enterprise Ltd Overview
Apollo Hospitals Enterprise Ltd is a leading healthcare provider in India, offering a wide range of medical services through its extensive network of hospitals. Known for its advanced technology and comprehensive patient care, it aims to set benchmarks in healthcare excellence.
The company has a market capitalization of ₹94,723 crore and is listed on both the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE). Currently, the stock is trading 17% below its 52-week high and 39.4% above its 52-week low.
Apollo Hospitals Enterprise Financial Results
Apollo Hospitals’ financial results for FY24 show Sales of ₹19,059 crore, a 30% increase from FY22. Despite rising expenses, Operating Profit reached ₹2,391 crore, with a Net Profit of ₹935 crore, down from ₹1,108 crore in FY22.
- Revenue Trend: Sales grew by 14.7% in FY24 to ₹19,059 crore, up from ₹16,613 crore in FY23. However, Operating Profit slightly increased to ₹2,391 crore in FY24.
- Equity and Liabilities: In FY24, the balance sheet reflects growth, with liabilities rising to support expanded operations. Liabilities increase, driven by capital expenditures and strategic investments.
- Profitability: Despite rising expenses, Apollo Hospitals’ OPM improved from 12% in FY23 to 13% in FY24. Net Profit, however, declined to ₹935 crore due to increased costs and higher tax rates.
- Earnings Per Share (EPS): EPS increased to ₹62.5 in FY24 from ₹56.97 in FY23, driven by higher revenues. However, it remains below FY22’s ₹73.42, reflecting the impact of lower net profits.
- Return on Net Worth (RoNW): RoNW indicates a stable performance in FY24, though slightly below FY23 levels. Increased profitability, reflected in EPS, supports overall shareholder returns.
- Financial Position: Apollo Hospitals’ financial position remains robust, with strategic investments supporting growth. The company maintains a healthy dividend payout ratio of 25.6% in FY24.
Apollo Hospitals Enterprise Financial Analysis
| FY 24 | FY 23 | FY 22 | |
| Sales | 19,059 | 16,613 | 14,663 |
| Expenses | 16,669 | 14,563 | 12,478 |
| Operating Profit | 2,391 | 2,050 | 2,185 |
| OPM % | 13 | 12 | 15 |
| Other Income | 108.2 | 90.3 | 372.3 |
| EBITDA | 2,497 | 2,140 | 2,263 |
| INTEREST | 449.4 | 380.8 | 378.6 |
| Depreciation | 687 | 615.4 | 600.7 |
| Profit Before Tax | 1,363 | 1,144 | 1,578 |
| Tax % | 32.7 | 22.4 | 30.23 |
| Net Profit | 935 | 844.3 | 1,108 |
| EPS | 62.5 | 56.97 | 73.42 |
| Dividend Payout % | 25.6 | 26.33 | 16 |
*All values in ₹ Crores
Apollo Hospitals Enterprise Company Metrics
Apollo Hospitals Enterprise Ltd, with a market capitalization of ₹94,723 crore and a current stock price of ₹6,588, reflects strong financial performance. The company shows robust metrics with a P/E ratio of 106, ROCE of 15.6%, and a solid return on equity of 13.7%, highlighting its stable market presence and growth potential.
- Market Cap: Apollo Hospitals Enterprise Ltd has a market capitalization of ₹94,723 crore, indicating its substantial market value and strong investor confidence.
- Book Value: The book value per share stands at ₹482, representing the net asset value attributable to each share.
- Face Value: The face value of Apollo Hospitals Enterprise Ltd shares is ₹5.00 per share.
- Turnover: Apollo Hospitals’ Asset Turnover ratio of 1.22 indicates efficient use of assets to generate revenue. This metric reflects the company’s operational efficiency in leveraging its assets.
- PE Ratio: With a price-to-earnings (P/E) ratio of 106, Apollo Hospitals’ stock is priced at a premium relative to its earnings. This high P/E ratio suggests investor expectations of significant future growth and profitability potential.
- Debt: The company carries a debt of ₹5,333 crore, reflecting its leverage level. While the debt supports expansion and operational needs, it also impacts financial stability and interest obligations.
- ROE: Apollo Hospitals has a return on equity (ROE) of 13.7%, indicating effective management and profitability relative to shareholder equity. This strong ROE demonstrates the company’s ability to generate returns on invested capital.
- EBITDA Margin: The EBITDA margin is 12.5%, showing the proportion of revenue remaining after operating expenses are deducted. This margin reflects Apollo Hospitals’ operational efficiency and its ability to maintain profitability amidst rising costs.
- Dividend Yield: The dividend yield is 0.24%, representing the annual dividend paid to shareholders as a percentage of the stock price.
Apollo Hospitals Enterprise Stock Performance
Over various time periods, Apollo Hospitals Enterprise Ltd has demonstrated strong returns on investment. The company achieved a 37% return over 5 years, 18% over 3 years, and 34% over the past year, reflecting consistent performance and robust growth potential in its market sector.
| Period | Return on Investment (%) |
| 5 Years | 37% |
| 3 Years | 18% |
| 1 Year | 34% |
Example:
If investor A put ₹1,00,000 into Apollo Hospitals Enterprise Ltd five years ago, with a 37% return on investment, their holding would now be worth ₹1,37,000, reflecting a profit of ₹37,000.
For a three-year investment, an 18% return would make it ₹1,18,000, gaining ₹18,000.
Over one year, a 34% return would increase it to ₹1,34,000, showing a ₹34,000 gain.
Apollo Hospitals Enterprise Peer Comparison
Apollo Hospitals, with a market cap of ₹93,728 crore, stands out among competitors in the healthcare sector. It has a robust 1-year return of 35.16% and a strong ROCE of 15.55%, indicating solid financial performance.
| S.No. | Name | CMP Rs. | Mar Cap Rs.Cr. | PEG | 3mth return % | 1Yr return % |
| 1 | Apollo Hospitals | 6515.85 | 93728.46 | 2.59 | 9.85 | 35.16 |
| 2 | Max Healthcare | 870 | 84581.91 | 0.1 | 2.47 | 66.76 |
| 3 | Fortis Health. | 522.15 | 39404.9 | 1.44 | 16.33 | 66.37 |
| 4 | Global Health | 1065.75 | 28633.63 | 1.06 | -23.6 | 57.8 |
| 5 | Dr. Lal Pathlabs | 3207.8 | 26725.07 | 5.63 | 27.2 | 41.56 |
| 6 | Narayana Hrudaya | 1178.15 | 24088.82 | 0.44 | -6.6 | 19.01 |
| 7 | Aster DM Health. | 388.15 | 19391.09 | -4.39 | 10.88 | 26.45 |
Apollo Hospitals Enterprise Shareholding Pattern
In June 2024, the ownership structure of Apollo Hospitals Enterprise Ltd showed promoters holding 29.33%, foreign institutional investors (FII) at 43.92%, domestic institutional investors (DII) at 21.13%, and retail investors at 5.61%. This distribution highlights a strong institutional presence and stable promoter holding.
| Jun 2024 | Mar 2024 | Dec 2023 | Sept 2023 | |
| Promoters | 29.33 | 29.33 | 29.33 | 29.33 |
| FII | 43.92 | 45.63 | 46.25 | 46.15 |
| DII | 21.13 | 19.55 | 18.87 | 18.59 |
| Retail & others | 5.61 | 5.49 | 5.55 | 5.91 |
*All values in %
Apollo Hospitals Enterprise History
Apollo Hospitals Enterprise Limited (AHEL) is a prominent private-sector healthcare provider in Asia, established on December 5, 1979. Initially starting as a 250-bed hospital in Chennai with a focus on specialty and super-specialty care, AHEL has expanded its presence across India and internationally.
Its network includes hospitals in major cities like Hyderabad, Delhi, and Mumbai, among others. The company has been a pioneer in corporate healthcare delivery in India and has introduced numerous innovations and expansions over the years, including advanced diagnostic technologies, cancer treatment facilities, and international ventures.
Notably, AHEL has established health insurance programs, partnerships for healthcare technology, and international collaborations, including ventures in Sri Lanka and China. It has also made significant investments in healthcare infrastructure, including the launch of the Apollo Proton Therapy Center and various acquisitions to strengthen its market position.
How To Invest In Apollo Hospitals Enterprise Ltd Share?
Investing in Apollo Hospitals Enterprise Ltd shares is a straightforward process:
- Open a Demat Account: Start by opening a Demat and trading account with a reliable brokerage firm like Alice Blue.
- Complete KYC: Submit necessary documents for KYC verification.
- Fund Your Account: Deposit funds into your trading account.
- Buy Shares: Search for Apollo Hospitals Enterprise Ltd shares and place your buy order.
Apollo Hospitals Enterprise Limited Fundamental Analysis – FAQs
Apollo Hospitals Enterprise Ltd’s fundamental analysis reveals a market cap of ₹94,723 crore, a PE ratio of 106, a debt-to-equity ratio of 0.77, and an ROE of 13.7%, indicating strong financial health and market valuation.
The market cap of Apollo Hospitals Enterprise Ltd as of August 11, 2024, is approximately ₹94,723 crore. This value reflects the company’s strong market position in the Indian cement industry.
Apollo Hospitals Enterprise Limited is a leading healthcare provider in India, offering a range of medical services including hospital care, diagnostics, and specialized treatments. It operates a network of hospitals and clinics, known for advanced healthcare facilities and services.
Apollo Hospitals Enterprise is primarily owned by the Reddy family, led by Dr. Prathap C. Reddy, the founder. The family retains significant control and ownership through their stakes and involvement in the company’s management and operations.
The main shareholders of Apollo Hospitals Enterprise include institutional investors, mutual funds, and significant individual shareholders. Key stakeholders often include the company’s founders, such as Dr. Prathap C. Reddy, and major investment firms with substantial holdings in the company.
Apollo Hospitals Enterprise operates in the healthcare industry, specifically focusing on hospital and healthcare services. It provides a range of medical services, including inpatient and outpatient care, diagnostics, and specialized treatments, across its network of hospitals and clinics.
To invest in Apollo Hospitals Enterprise Ltd shares, open a brokerage account, research the company’s financial health, and monitor stock performance. Place buy orders through your brokerage platform, and consider diversifying your portfolio to manage risk effectively.
Determining if Apollo Hospitals Enterprise is overvalued or undervalued requires a comprehensive analysis of its financials, growth prospects, industry trends, and market conditions. Investors should consider metrics like the P/E ratio and PEG ratio, and compare them with industry peers and historical values for a balanced assessment.
We hope you’re clear on the topic, but there’s more to explore in stocks, commodities, mutual funds, and related areas. Here are important topics to learn about.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
